T-Cell Lymphoma Clinical Trials

A listing of T-Cell Lymphoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 185 clinical trials
Letermovir for the Prevention of Cytomegalovirus Reactivation in Patients With Hematological Malignancies Treated With Alemtuzumab

This phase II trial studies how well letermovir works for the prevention of cytomegalovirus reactivation in patients with hematological malignancies treated with alemtuzumab. Patients receiving treatment with alemtuzumab may experience cytomegalovirus reactivation. Letermovir may block cytomegalovirus replication and prevent infection.

  • 0 views
  • 15 Mar, 2021
  • 1 location
Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma

This research study will test OT-82, which is an investigational ("research" or "experimental" ) drug. The study has two stages (Stage 1 and Stage 2). The purpose of Stage 1 is to determine the safety and tolerability and the maximum tolerated dose (MTD) or the maximum tested dose of OT-82 …

t-cell lymphoma
measurable disease
peripheral t-cell lymphoma
refractory lymphoma
cancer
  • 3 views
  • 26 Jan, 2021
  • 8 locations
VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Patients With Relapsed or Refractory Multiple Myeloma Acute Myeloid Leukemia or T-cell Lymphoma

without ruxolitinib phosphate in treating patients with multiple myeloma, acute myeloid leukemia, or T-cell lymphoma that has come back or does not respond to treatment. A virus, called VSV-hIFNbeta-NIS

t-cell lymphoma
measurable disease
alkylating agent
biological therapy
monoclonal antibody therapy
  • 40 views
  • 08 Apr, 2021
  • 4 locations
Camrelizumab Pegaspargase and Apatinib With Radiation Therapy for Stage IE/IIE ENKTL

patients with de novo stage IE/IIE extranodal natural killer/T-cell lymphoma, nasal type.

  • 0 views
  • 14 Feb, 2021
  • 2 locations
Autologous Cells Derived Anti-CD7 CAR-Engineered T Cells for T Lymphoid Malignancies

This is a single-center, open-label, single-arm study to evaluate the primary safety and efficacy of autologous anti-CD7 chimeric antigen receptor(CAR)-modified T cells(CAR7-Ts) in patients with relapsed or refractory T lymphoid malignancies.

  • 0 views
  • 16 Apr, 2021
  • 1 location
CD30 Targeted CAR-T in Treating CD30-Expressing Lymphomas

CAR-T cells have been validated effective in treating CD19 positive B cell lymphoma. Other lymphomas like Hodgkin's lymphoma and anaplastic large cell lymphoma are CD30 positive. In this study, a newly CD30 targeted CART therapy ICAR30 is designed to specifically kill those CD30 expressing malignancies including Hodgkin's lymphoma and CD30+ …

cancer
lymphoma
b-cell lymphoma
hodgkin's disease
  • 7 views
  • 21 Jan, 2021
  • 1 location
A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies

This study evaluates the safety, pharmacokinetics, and efficacy of BP1002 (L-Bcl-2) antisense oligonucleotide in patients with advanced lymphoid malignancies. Up to 12 evaluable patients with a diagnosis of relapsed or refractory lymphoid malignancies are expected to participate.

mantle cell lymphoma
peripheral t-cell lymphoma
marginal zone lymphoma
chronic lymphocytic leukemia
stem cell transplantation
  • 0 views
  • 03 Feb, 2021
  • 3 locations
Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies

safest. If the combination is determined to be safe, the study will continue accrual patients with peripheral T-Cell lymphoma (PTCL).

t-cell lymphoma
chemotherapy regimen
peripheral t-cell lymphoma
cancer
lymphoma
  • 11 views
  • 24 Jan, 2021
  • 2 locations
Allogeneic CD30.CAR-EBVSTs in Patients With Relapsed or Refractory CD30-Positive Lymphomas

This study involved patients that have a cancer called diffuse large B cell lymphoma (DLBCL), NK and T cell lymphomas (NK/TL) or classical Hodgkin lymphoma (cHL) (hereafter these 3 diseases will be referred to as lymphoma). Patients lymphoma has come back or not gone away after treatment. Because there is …

  • 0 views
  • 08 Apr, 2021
  • 2 locations
Mechanisms of Action of Photo(Chemo)Therapy in Skin Diseases

The molecular mechanisms of action of photo(chemo)therapy in skin diseases are investigated in this study. The phototherapeutic modalities employed include UVB (ultraviolet B), UVA (ultraviolet A), PUVA (psoralen+UVA) and/or extracorporeal photochemotherapy (photopheresis). The study will address whether and how photo(chemo)therapy affects specific biologic pathways in different skin disorders and search …

skin disorder
extracorporeal photopheresis
chemotherapy regimen
psoralen
puva
  • 192 views
  • 21 Jan, 2021
  • 1 location